HEADER HYDROLASE 31-JUL-08 3E0P TITLE THE X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH A COVALENT TITLE 2 BENZOXAZOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROSTASIN; COMPND 3 CHAIN: B; COMPND 4 FRAGMENT: UNP RESIDUES 45-305; COMPND 5 SYNONYM: SERINE PROTEASE 8, PROSTASIN LIGHT CHAIN, PROSTASIN HEAVY COMPND 6 CHAIN; COMPND 7 EC: 3.4.21.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRSS8; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROSTASIN, PROTEASE, BENZOXAZOLE, WARHEAD, CHANNEL, ENAC, CELL KEYWDS 2 MEMBRANE, GLYCOPROTEIN, HYDROLASE, MEMBRANE, SECRETED, SERINE KEYWDS 3 PROTEASE, TRANSMEMBRANE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR G.SPRAGGON,M.HORNSBY,A.SHIPWAY,J.L.HARRIS,S.A.LESLEY REVDAT 5 20-OCT-21 3E0P 1 REMARK SEQADV REVDAT 4 13-JUL-11 3E0P 1 VERSN REVDAT 3 24-FEB-09 3E0P 1 VERSN REVDAT 2 25-NOV-08 3E0P 1 JRNL REVDAT 1 09-SEP-08 3E0P 0 JRNL AUTH D.C.TULLY,A.VIDAL,A.K.CHATTERJEE,J.A.WILLIAMS,M.J.ROBERTS, JRNL AUTH 2 H.M.PETRASSI,G.SPRAGGON,B.BURSULAYA,R.PACOMA,A.SHIPWAY, JRNL AUTH 3 A.M.SCHUMACHER,H.DANAHAY,J.L.HARRIS JRNL TITL DISCOVERY OF INHIBITORS OF THE CHANNEL-ACTIVATING PROTEASE JRNL TITL 2 PROSTASIN (CAP1/PRSS8) UTILIZING STRUCTURE-BASED DESIGN. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 5895 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18752942 JRNL DOI 10.1016/J.BMCL.2008.08.029 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 26696 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1355 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 1.7600 - 1.7000 0.99 0 150 0.2337 0.2934 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.37100 REMARK 3 B22 (A**2) : -0.16460 REMARK 3 B33 (A**2) : -2.20640 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 ELECTRON DENSITY FOR THE P3 AND P4 R GROUPS WAS WEAK; POSITIONS REMARK 3 WERE REMARK 3 TENTATIVELY MODELED ON THE BASIS OF MAIN CHAIN INHIBITOR HYDROGEN REMARK 3 BONDING AS EXHIBITED IN PDB ENTRY 3E16 REMARK 4 REMARK 4 3E0P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000048727. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26861 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : 0.10100 REMARK 200 FOR THE DATA SET : 18.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.57900 REMARK 200 R SYM FOR SHELL (I) : 0.57900 REMARK 200 FOR SHELL : 1.870 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% PEGME-5000 BUFFERED WITH 0.1M MES, REMARK 280 PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.24200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.58950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.58950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.24200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG B 248 REMARK 465 VAL B 249 REMARK 465 VAL B 250 REMARK 465 PRO B 251 REMARK 465 GLN B 252 REMARK 465 THR B 253 REMARK 465 GLN B 254 REMARK 465 GLU B 255 REMARK 465 SER B 256 REMARK 465 GLN B 257 REMARK 465 PRO B 258 REMARK 465 ASP B 259 REMARK 465 SER B 260 REMARK 465 ASN B 261 REMARK 465 LEU B 262 REMARK 465 HIS B 263 REMARK 465 HIS B 264 REMARK 465 HIS B 265 REMARK 465 HIS B 266 REMARK 465 HIS B 267 REMARK 465 HIS B 268 REMARK 465 HIS B 269 REMARK 465 HIS B 270 REMARK 465 HIS B 271 REMARK 465 HIS B 272 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 195 C45 B3C B 1 1.70 REMARK 500 NE2 HIS B 71 O HOH B 443 2.03 REMARK 500 O HOH B 367 O HOH B 468 2.10 REMARK 500 O HOH B 367 O HOH B 470 2.17 REMARK 500 C22 B3C B 1 O HOH B 369 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 100 -164.30 -166.18 REMARK 500 LYS B 153 65.11 66.18 REMARK 500 PRO B 172I 95.17 -61.78 REMARK 500 SER B 195 132.67 -39.81 REMARK 500 SER B 214 -62.90 -124.81 REMARK 500 ASP B 217 -155.85 -98.39 REMARK 500 GLN B 246 77.29 -170.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 B3C B 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B3C B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 273 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3E0N RELATED DB: PDB REMARK 900 PROSTASIN IN COMPLEX WITH CHLOROMETHYL KETONE INHIBITOR REMARK 900 RELATED ID: 3E16 RELATED DB: PDB REMARK 900 RELATED ID: 3E1X RELATED DB: PDB DBREF 3E0P B 16 262 UNP Q16651 PRSS8_HUMAN 45 305 SEQADV 3E0P SER B 122 UNP Q16651 CYS 154 ENGINEERED MUTATION SEQADV 3E0P GLN B 127 UNP Q16651 ASN 159 ENGINEERED MUTATION SEQADV 3E0P SER B 170 UNP Q16651 CYS 203 ENGINEERED MUTATION SEQADV 3E0P HIS B 263 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 264 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 265 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 266 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 267 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 268 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 269 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 270 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 271 UNP Q16651 EXPRESSION TAG SEQADV 3E0P HIS B 272 UNP Q16651 EXPRESSION TAG SEQRES 1 B 271 ILE THR GLY GLY SER SER ALA VAL ALA GLY GLN TRP PRO SEQRES 2 B 271 TRP GLN VAL SER ILE THR TYR GLU GLY VAL HIS VAL CYS SEQRES 3 B 271 GLY GLY SER LEU VAL SER GLU GLN TRP VAL LEU SER ALA SEQRES 4 B 271 ALA HIS CYS PHE PRO SER GLU HIS HIS LYS GLU ALA TYR SEQRES 5 B 271 GLU VAL LYS LEU GLY ALA HIS GLN LEU ASP SER TYR SER SEQRES 6 B 271 GLU ASP ALA LYS VAL SER THR LEU LYS ASP ILE ILE PRO SEQRES 7 B 271 HIS PRO SER TYR LEU GLN GLU GLY SER GLN GLY ASP ILE SEQRES 8 B 271 ALA LEU LEU GLN LEU SER ARG PRO ILE THR PHE SER ARG SEQRES 9 B 271 TYR ILE ARG PRO ILE SER LEU PRO ALA ALA GLN ALA SER SEQRES 10 B 271 PHE PRO ASN GLY LEU HIS CYS THR VAL THR GLY TRP GLY SEQRES 11 B 271 HIS VAL ALA PRO SER VAL SER LEU LEU THR PRO LYS PRO SEQRES 12 B 271 LEU GLN GLN LEU GLU VAL PRO LEU ILE SER ARG GLU THR SEQRES 13 B 271 CYS ASN SER LEU TYR ASN ILE ASP ALA LYS PRO GLU GLU SEQRES 14 B 271 PRO HIS PHE VAL GLN GLU ASP MET VAL CYS ALA GLY TYR SEQRES 15 B 271 VAL GLU GLY GLY LYS ASP ALA CYS GLN GLY ASP SER GLY SEQRES 16 B 271 GLY PRO LEU SER CYS PRO VAL GLU GLY LEU TRP TYR LEU SEQRES 17 B 271 THR GLY ILE VAL SER TRP GLY ASP ALA CYS GLY ALA ARG SEQRES 18 B 271 ASN ARG PRO GLY VAL TYR THR LEU ALA SER SER TYR ALA SEQRES 19 B 271 SER TRP ILE GLN SER LYS VAL THR GLU LEU GLN PRO ARG SEQRES 20 B 271 VAL VAL PRO GLN THR GLN GLU SER GLN PRO ASP SER ASN SEQRES 21 B 271 LEU HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HET B3C B 1 57 HET GOL B 273 6 HETNAM B3C BENZYL [(1R)-1-({(2S,4R)-2-({(1S)-5-AMINO-1-[(S)-1,3- HETNAM 2 B3C BENZOXAZOL-2-YL(HYDROXY)METHYL]PENTYL}CARBAMOYL)-4- HETNAM 3 B3C [(4-METHYLBENZYL)OXY]PYRROLIDIN-1-YL}CARBONYL)-3- HETNAM 4 B3C PHENYLPROPYL]CARBAMATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 B3C C44 H51 N5 O7 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *206(H2 O) HELIX 1 1 ALA B 55 PHE B 58A 5 5 HELIX 2 2 HIS B 58F GLU B 58H 5 3 HELIX 3 3 HIS B 91 GLU B 97 1 7 HELIX 4 4 SER B 164 ILE B 172B 1 11 HELIX 5 5 TYR B 234 GLN B 246 1 13 SHEET 1 A 8 SER B 20 SER B 21 0 SHEET 2 A 8 GLN B 156 ILE B 163 -1 O GLN B 157 N SER B 20 SHEET 3 A 8 MET B 180 ALA B 183 -1 O CYS B 182 N ILE B 163 SHEET 4 A 8 GLY B 226 LEU B 230 -1 O TYR B 228 N VAL B 181 SHEET 5 A 8 LEU B 206 TRP B 215 -1 N TRP B 215 O VAL B 227 SHEET 6 A 8 PRO B 198 VAL B 203 -1 N CYS B 201 O TYR B 208 SHEET 7 A 8 HIS B 135 GLY B 140 -1 N THR B 137 O SER B 200 SHEET 8 A 8 GLN B 156 ILE B 163 -1 O VAL B 160 N CYS B 136 SHEET 1 B 7 LYS B 81 SER B 83 0 SHEET 2 B 7 TYR B 64 LEU B 68 -1 N LEU B 68 O LYS B 81 SHEET 3 B 7 GLN B 30 TYR B 35 -1 N THR B 34 O GLU B 65 SHEET 4 B 7 VAL B 39 LEU B 46 -1 O CYS B 42 N ILE B 33 SHEET 5 B 7 TRP B 51 SER B 54 -1 O LEU B 53 N SER B 45 SHEET 6 B 7 ALA B 104 LEU B 108 -1 O LEU B 106 N VAL B 52 SHEET 7 B 7 LEU B 85 PRO B 90 -1 N ILE B 89 O LEU B 105 SSBOND 1 CYS B 42 CYS B 58 1555 1555 2.02 SSBOND 2 CYS B 136 CYS B 201 1555 1555 2.03 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.04 SSBOND 4 CYS B 191 CYS B 219 1555 1555 2.02 CISPEP 1 THR B 144H PRO B 144I 0 5.26 SITE 1 AC1 24 HIS B 57 GLU B 97 GLY B 98 SER B 99 SITE 2 AC1 24 GLN B 100 ASP B 102 PRO B 172I ASP B 189 SITE 3 AC1 24 ALA B 190 CYS B 191 GLN B 192 GLY B 193 SITE 4 AC1 24 ASP B 194 SER B 195 SER B 214 TRP B 215 SITE 5 AC1 24 GLY B 216 ASP B 217 ALA B 218 GLY B 226 SITE 6 AC1 24 HOH B 349 HOH B 369 HOH B 376 HOH B 445 SITE 1 AC2 6 SER B 122 LEU B 206 TRP B 207 SER B 236 SITE 2 AC2 6 HOH B 290 HOH B 451 CRYST1 52.484 54.240 83.179 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019053 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018437 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012022 0.00000